Related references
Note: Only part of the references are listed.T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2009)
A heterocyclic molecule with significant activity against dengue virus
Vasu Nair et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Persistence of Leukemia-Initiating Cells in a Conditional Knockin Model of an Imatinib-Responsive Myeloproliferative Disorder
Katherine I. Oravecz-Wilson et al.
CANCER CELL (2009)
IMP Dehydrogenase: Structure, Mechanism, and Inhibition
Lizbeth Hedstrom
CHEMICAL REVIEWS (2009)
Taribavirin: a potential alternative to ribavirin
Fred F. Poordad et al.
FUTURE VIROLOGY (2009)
Expression of IMPDH1 is regulated in response to mycophenolate concentration
Sara Bremer et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
A Phase I Dose-Ranging Study of the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of AVN944, an IMPDH Inhibitor, in Healthy Male Volunteers
J. Michael Hamilton et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Triazole Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase
Sushil K. Maurya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study
Sara Bremer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
The Necrotic Signal Induced by Mycophenolic Acid Overcomes Apoptosis-Resistance in Tumor Cells
Gwendaline Guidicelli et al.
PLOS ONE (2009)
A New Kind of DRUG TARGET
Melinda Wenner
SCIENTIFIC AMERICAN (2009)
A kinetic alignment of orthologous inosine-5′-monophosphate dehydrogenases
Thomas V. Riera et al.
BIOCHEMISTRY (2008)
Targeting a prokaryotic protein in a eukaryotic pathogen: Identification of lead compounds against cryptosporidiosis
Nwakaso N. Umejiego et al.
CHEMISTRY & BIOLOGY (2008)
Taribavirin for the treatment of chronic hepatitis C
Keith R. Kearney et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells
Daniel Floryk et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The Immunosuppressor Mycophenolic Acid Kills Activated Lymphocytes by Inducing a Nonclassical Actin-Dependent Necrotic Signal
Benjamin Chaigne-Delalande et al.
JOURNAL OF IMMUNOLOGY (2008)
The CBS subdomain of inosine 5'-monophosphate dehydrogenase regulates purine nucleotide turnover
Maxim Pimkin et al.
MOLECULAR MICROBIOLOGY (2008)
Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery
Qingning Shu et al.
MEDICINAL RESEARCH REVIEWS (2008)
An enzymatic atavist revealed in dual pathways for water activation
Donghong Min et al.
PLOS BIOLOGY (2008)
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment
Liqiang Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A CBS domain-containing pyrophosphatase of Moorella thermoacetica is regulated by adenine nucleotides
Joonas Jamsen et al.
BIOCHEMICAL JOURNAL (2007)
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling
Jeffrey Haessler et al.
CLINICAL CANCER RESEARCH (2007)
Phase 2 study of the combination of merimepodib with peginterferon-α2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2007)
Getting to the root of cancer
Sarah Everts
CHEMICAL & ENGINEERING NEWS (2007)
IMPDH as a biological probe for RNA antiviral drug discovery: Synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases
Vasu Nair et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2007)
Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5
Sebastian Meyer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
IMP dehydrogenase: structural schizophrenia and an unusual base
Lizbeth Hedstrom et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
Treating HCV with ribavirin analogues and ribavirin-like molecules
RG Gish
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Guanidine derivatives rescue the Arg418Ala mutation of Tritrichomonas foetus IMP dehydrogenase
YVG Schlippe et al.
BIOCHEMISTRY (2005)
Cytoplasmic ATP-sensing domains regulate gating of skeletal muscle ClC-1 chloride channels
B Bennetts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Is Arg418 the catalytic base required for the hydrolysis step of the IMP dehydrogenase reaction?
YVG Schlippe et al.
BIOCHEMISTRY (2005)
Autosomal dominant retinitis pigmentosa mutations in inosine 5′-monophosphate dehydrogenase type I disrupt nucleic acid binding
SE Mortimer et al.
BIOCHEMICAL JOURNAL (2005)
Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl
JJ Gu et al.
BLOOD (2005)
A twisted base? The role of arginine in enzyme-catalyzed proton abstractions
YVG Schlippe et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction
YVG Schlippe et al.
BIOCHEMISTRY (2004)
Cofactor mimics as selective inhibitors of NAD-dependent inosine monophospate dehydrogenase (IMPDH) - the major therapeutic target
KW Pankiewicz et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes
J Jain et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Dual-action mechanism of viramidine functioning as a prodrug and as a catabolic inhibitor for ribavirin
JZ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Targeted disruption of the inosine 5′-monophosphate dehydrogenase type I gene in mice
JJ Gu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA
SF Zhou et al.
VIROLOGY (2003)
Crystal structures of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs:: A structural basis for the random-in ordered-out kinetic mechanism
GL Prosise et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase
L Gan et al.
BIOCHEMISTRY (2003)
Activation and deactivation of a broad-spectrum antiviral drug by a single enzyme: Adenosine deaminase catalyzes two consecutive deamination reactions
JZ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site
GL Prosise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5′-monophosphate dehydrogenase:: NAD+ orients the active site loop for catalysis
L Gan et al.
BIOCHEMISTRY (2002)
Inhibition of inosine monophosphate dehydrogenase (IMPDH) by the antiviral compound, 2-vinylinosine monophosphate
S Pal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Identification of G protein-coupled receptor genes from the human genome sequence (vol 520, pg 97, 2002)
S Takeda et al.
FEBS LETTERS (2002)
Worldwide incidence of multidrug-resistant tuberculosis
C Dye et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa
SJ Bowne et al.
HUMAN MOLECULAR GENETICS (2002)
Regulation of human cystathionine β-synthase by S-adenosyl-L-methionine:: Evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region
M Janosík et al.
BIOCHEMISTRY (2001)
Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes
RE Lanford et al.
JOURNAL OF VIROLOGY (2001)
Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents
KW Pankiewicz
EXPERT OPINION ON THERAPEUTIC PATENTS (2001)
RNA virus error catastrophe: Direct molecular test by using ribavirin
S Crotty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Selective inhibition of human molt-4 leukemia type II inosine 5′-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones
BJ Barnes et al.
BIOCHEMISTRY (2000)
VX-497.: Anti-HCV, antipsoriatic, IMPDH inhibitor.
LA Sorbera et al.
DRUGS OF THE FUTURE (2000)
Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5′-monophosphate dehydrogenase:: Evidence of a substrate-induced hinged-lid motion by loop 6
FM McMillan et al.
BIOCHEMISTRY (2000)
Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon
W Markland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Drug selectivity is determined by coupling across the NAD+ site of IMP dehydrogenase
JA Digits et al.
BIOCHEMISTRY (2000)
Differentiation induction in non-lymphocytic leukemia cells upon treatment with mycophenolate mofetil
K Inai et al.
LEUKEMIA RESEARCH (2000)
Share Paper
